Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob George

Showing results (161-170 of 971) with videos related to

Pageof 98
Sort By:
Trends in Genetics : TIG|May 13, 2020
The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver DiseaseAli Bayoumi, Henning Grønbæk, Jacob George, et al.
Molecular Cancer|January 4, 2022
Single cell RNA-seq analysis identifies a noncoding RNA mediating resistance to sorafenib treatment in HCCKevin Zhou, Romario Nguyen, Liang Qiao, et al.
Expert Review of Gastroenterology & Hepatology|August 21, 2015
The benefits of exercise for patients with non-alcoholic fatty liver diseaseShelley E Keating, Jacob George, Nathan A Johnson
European Journal of Pharmacology|June 17, 2009
Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic miceAdi Mor, Yoel Kloog, Gad Keren, et al.
Seminars in Liver Disease|March 16, 2012
Exercise and the liver: implications for therapy in fatty liver disordersNathan A Johnson, Shelley E Keating, Jacob George
European Journal of Immunology|May 8, 2008
N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cellsAdi Mor, Gad Keren, Yoel Kloog, et al.
Hepatology International|August 28, 2024
Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLDMingqian Jiang, Ziyan Pan, Jacob George, et al.
Journal of Hypertension|May 14, 2025
Breaking down resistance: novel aldosterone synthase inhibitors in the management of resistant hypertensionChai Eddison Chung Hung, Cyril Kocherry, Jacob George
Hepatology International|March 15, 2025
Global prevalence, metabolic characteristics, and outcomes of lean-MAFLD: a systematic review and meta-analysisMark C C Cheah, Harry Crane, Jacob George
Current Gene Therapy|December 25, 2014
Targeting cancer stem cells as a therapeutic approach in liver cancerGang Zhou, George Wilson, Jacob George, et al.
Pageof 98

Showing results (161-170 of 971) with videos related to

Sort By:
Pageof 98
Trends in Genetics : TIG|May 13, 2020
The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver DiseaseAli Bayoumi, Henning Grønbæk, Jacob George, et al.
Molecular Cancer|January 4, 2022
Single cell RNA-seq analysis identifies a noncoding RNA mediating resistance to sorafenib treatment in HCCKevin Zhou, Romario Nguyen, Liang Qiao, et al.
Expert Review of Gastroenterology & Hepatology|August 21, 2015
The benefits of exercise for patients with non-alcoholic fatty liver diseaseShelley E Keating, Jacob George, Nathan A Johnson
European Journal of Pharmacology|June 17, 2009
Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic miceAdi Mor, Yoel Kloog, Gad Keren, et al.
Seminars in Liver Disease|March 16, 2012
Exercise and the liver: implications for therapy in fatty liver disordersNathan A Johnson, Shelley E Keating, Jacob George
European Journal of Immunology|May 8, 2008
N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cellsAdi Mor, Gad Keren, Yoel Kloog, et al.
Hepatology International|August 28, 2024
Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLDMingqian Jiang, Ziyan Pan, Jacob George, et al.
Journal of Hypertension|May 14, 2025
Breaking down resistance: novel aldosterone synthase inhibitors in the management of resistant hypertensionChai Eddison Chung Hung, Cyril Kocherry, Jacob George
Hepatology International|March 15, 2025
Global prevalence, metabolic characteristics, and outcomes of lean-MAFLD: a systematic review and meta-analysisMark C C Cheah, Harry Crane, Jacob George
Current Gene Therapy|December 25, 2014
Targeting cancer stem cells as a therapeutic approach in liver cancerGang Zhou, George Wilson, Jacob George, et al.
Pageof 98